Literature DB >> 22969960

Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis.

Mu-Han Lü1, Jia-Qi Deng, Ya-Ling Cao, Dian-Chun Fang, Yao Zhang, Shi-Ming Yang.   

Abstract

Activation of telomerase is involved in carcinogenesis in most types of cancers. However, the prognostic value of telomerase activity (TA) in patients with gastric carcinoma (GC) remains controversial. We conducted a meta-analysis to assess the relationship between TA and the clinical outcome of GC. A meta-analysis of 18 studies (886 patients) was performed to evaluate the association between TA and metastasis-related parameters in GC patients by searching databases, including PubMed, MEDLINE, EMBASE, Web of Science databases, Cochrane Library and the Chinese Biomedical Literature database (CBM) (last search updated in October 2011). We used the odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association between TA and metastasis of GC. Our analysis results indicated that high telomerase activity expression tended to be associated with the presence of lymph node metastasis (866 patients) (OR=2.03, 95% CI 1.21-3.39, p=0.007), the depth of invasion (886 patients) (OR=1.87, 95% CI 1.30-2.70, p=0.0007), distant metastasis (407 patients) (OR=2.71, 95% CI 1.59-4.63, p=0.0002), tumor size (466 patients) (OR=2.14, 95% CI 1.31-3.50, p=0.002) and TNM stage (711 patients) (OR=2.39, 95% CI 1.30-4.41, p=0.005). However, high TA expression was not associated with the presence of histologic differentiation (791 patients) (OR=1.51, 95% CI 0.73-3.11, p=0.26). In conclusion, telomerase overexpression not only plays a key role in primary initiation, but also promotes invasion and metastatic progression of GC. These findings raise the possibility of using TA to screen for the prognosis of gastric cancer.

Entities:  

Year:  2012        PMID: 22969960      PMCID: PMC3438691          DOI: 10.3892/etm.2012.471

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  46 in total

Review 1.  Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT).

Authors:  J C Poole; L G Andrews; T O Tollefsbol
Journal:  Gene       Date:  2001-05-16       Impact factor: 3.688

Review 2.  Epidemiology of gastric cancer.

Authors:  D Palli
Journal:  Ann Ist Super Sanita       Date:  1996       Impact factor: 1.663

3.  Telomerase activity in gastric cancer and its clinical implications.

Authors:  Wen-Hua Zhan; Jin-Ping Ma; Jun-Sheng Peng; Jing-Song Gao; Shi-Rong Cai; Jian-Ping Wang; Zhang-Qing Zheng; Lei Wang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

4.  Detection of cancer cells in peripheral blood of stomach cancer patients using RT-PCR amplification of tumour-specific mRNAs.

Authors:  J-H Shin; J Chung; H-O Kim; Y-H Kim; Y-M Hur; J-H Rhim; H-K Chung; S-C Park; J-G Park; H-K Yang
Journal:  Aliment Pharmacol Ther       Date:  2002-04       Impact factor: 8.171

5.  Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas.

Authors:  Jinyoung Yoo; Sonya Y Park; Seok Jin Kang; Byung Kee Kim; Sang In Shim; Chang Suk Kang
Journal:  Mod Pathol       Date:  2003-07       Impact factor: 7.842

Review 6.  The epidemiology of gastric cancer.

Authors:  David M Roder
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

7.  [Gastric cancer - current state of the problem. Part I. Epidemiology. Pathology. Classification. Staging].

Authors:  D Bulanov
Journal:  Khirurgiia (Sofiia)       Date:  2007

8.  Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.

Authors:  H Tahara; H Kuniyasu; H Yokozaki; W Yasui; J W Shay; T Ide; E Tahara
Journal:  Clin Cancer Res       Date:  1995-11       Impact factor: 12.531

9.  Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome.

Authors:  Lingeng Lu; Chong Zhang; Gongjian Zhu; Melinda Irwin; Harvey Risch; Guido Menato; Marco Mitidieri; Dionyssios Katsaros; Herbert Yu
Journal:  Breast Cancer Res       Date:  2011-06-06       Impact factor: 6.466

10.  Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas.

Authors:  W Yasui; H Tahara; E Tahara; J Fujimoto; J Nakayama; F Ishikawa; T Ide; E Tahara
Journal:  Jpn J Cancer Res       Date:  1998-11
View more
  11 in total

1.  The Relationship between Telomerase Activity and Clinicopathological Parameters in Colorectal Cancer: A Meta-Analysis.

Authors:  Xue-Cheng Xie; Lian-Ying Ge; Hao Lai; Hai Qiu; Fan Tang; Yu-Zhou Qin
Journal:  Balkan Med J       Date:  2016-01-01       Impact factor: 2.021

2.  A meta-analysis: to compare the clinical results between gastric bypass and sleeve gastrectomy for the obese patients.

Authors:  Xuechao Yang; Guang Yang; Wensheng Wang; Guoqing Chen; Hua Yang
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

3.  Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer.

Authors:  M-H Lü; B Tang; S Zeng; C-J Hu; R Xie; Y-Y Wu; S-M Wang; F-T He; S-M Yang
Journal:  Oncogene       Date:  2015-11-09       Impact factor: 9.867

4.  Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer.

Authors:  Tomoya Kato; Mikihito Nakamori; Shuichi Matsumura; Masaki Nakamura; Toshiyasu Ojima; Hiroshi Fukuhara; Yasushi Ino; Tomoki Todo; Hiroki Yamaue
Journal:  Oncol Lett       Date:  2021-04-23       Impact factor: 2.967

Review 5.  Inhibition of telomerase activity by NME2: impact on metastasis suppression?

Authors:  Anirban Kar; Shantanu Chowdhury
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-12-31       Impact factor: 3.000

6.  miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.

Authors:  L Chen; M-H Lü; D Zhang; N-B Hao; Y-H Fan; Y-Y Wu; S-M Wang; R Xie; D-C Fang; H Zhang; C-J Hu; S-M Yang
Journal:  Cell Death Dis       Date:  2014-01-30       Impact factor: 8.469

7.  hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a.

Authors:  Bing He; Yu-Feng Xiao; Bo Tang; Yu-Yun Wu; Chang-Jiang Hu; Rui Xie; Xin Yang; Song-Tao Yu; Hui Dong; Xiao-Yan Zhao; Ji-Liang Li; Shi-Ming Yang
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

8.  Genetic polymorphisms in TERT are associated with increased risk of esophageal cancer.

Authors:  Yifei Wu; Mengdan Yan; Jing Li; Jingjie Li; Zhengshuai Chen; Peng Chen; Bin Li; Fulin Chen; Tianbo Jin; Chao Chen
Journal:  Oncotarget       Date:  2017-02-07

9.  Genetic variants in TERT are associated with risk of gastric cancer in a Chinese Han population.

Authors:  Xianglong Duan; Wei Cao; Lijie Wang; Sida Liu; Zhao Liu; Bolun Zhang; Hua Yang; Tian Feng; Jiayi Zhang; Xiyang Zhang; Yanbin Long; Tianbo Jin
Journal:  Oncotarget       Date:  2016-12-13

10.  An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.

Authors:  Yong Qin; Bo Tang; Chang-Jiang Hu; Yu-Feng Xiao; Rui Xie; Xin Yong; Yu Yun Wu; Hui Dong; Shi-Ming Yang
Journal:  Oncotarget       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.